Total Payments
$2,713
2024 Payments
$1,049
Companies
33
Transactions
145
Medicare Patients
1,387
Medicare Billing
$93,450
Payment Breakdown by Category
Food & Beverage$2,713 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,713 | 145 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $631.40 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $448.85 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $309.38 | 21 | $0 (2024) |
| Lilly USA, LLC | $213.44 | 14 | $0 (2024) |
| PFIZER INC. | $195.53 | 13 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $124.74 | 1 | $0 (2024) |
| Amgen Inc. | $105.40 | 7 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $73.33 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.21 | 4 | $0 (2023) |
| Dexcom, Inc. | $52.78 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,049 | 45 | AstraZeneca Pharmaceuticals LP ($208.62) |
| 2023 | $779.92 | 39 | AstraZeneca Pharmaceuticals LP ($215.99) |
| 2022 | $591.13 | 41 | Novo Nordisk Inc ($205.73) |
| 2021 | $292.72 | 20 | Novo Nordisk Inc ($135.99) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 11/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Biological | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Central Nervous System | ||||||
| 07/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 07/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neurology | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 583 | 844 | $152,130 | $43,873 |
| 2022 | 14 | 464 | 782 | $127,145 | $31,831 |
| 2021 | 5 | 199 | 240 | $42,448 | $11,610 |
| 2020 | 5 | 141 | 220 | $21,788 | $6,136 |
Total Patients
1,387
Total Services
2,086
Medicare Billing
$93,450
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 231 | $58,674 | $13,327 | 22.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 40 | 40 | $26,480 | $11,316 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $17,536 | $6,604 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 79 | $13,588 | $3,837 | 28.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 40 | 42 | $6,972 | $3,156 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 48 | $1,776 | $1,373 | 77.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 43 | 43 | $1,591 | $1,230 | 77.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 102 | $8,160 | $971.04 | 11.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 26 | 27 | $5,400 | $865.56 | 16.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 85 | $7,650 | $629.52 | 8.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 44 | 54 | $3,672 | $410.94 | 11.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 13 | 14 | $196.00 | $102.74 | 52.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $435.00 | $51.15 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 333 | $84,582 | $21,092 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $4,932 | $1,862 | 37.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 34 | 36 | $2,830 | $1,480 | 52.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,459 | $1,426 | 32.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 47 | $1,739 | $1,268 | 72.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 22 | 28 | $5,600 | $852.99 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 17 | $2,924 | $765.80 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 80 | $6,400 | $762.09 | 11.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 73 | $6,570 | $586.40 | 8.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $666.00 | $486.57 | 73.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 47 | 63 | $4,284 | $482.79 | 11.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $702.00 | $453.62 | 64.6% |
About Meaghan Gift
Meaghan Gift is a Family healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1336532019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meaghan Gift has received a total of $2,713 in payments from pharmaceutical and medical device companies, with $1,049 received in 2024. These payments were reported across 145 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,713).
As a Medicare-enrolled provider, Gift has provided services to 1,387 Medicare beneficiaries, totaling 2,086 services with total Medicare billing of $93,450. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Louisville, KY
- Active Since 03/05/2015
- Last Updated 10/29/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1336532019
Products in Payments
- Ozempic (Drug) $353.39
- TRELEGY ELLIPTA (Drug) $294.87
- BREZTRI (Drug) $234.86
- FARXIGA (Drug) $213.99
- PREVNAR 20 (Biological) $151.61
- Rybelsus (Drug) $143.79
- VOQUEZNA (Drug) $124.74
- TRULICITY (Drug) $122.93
- MOUNJARO (Drug) $90.51
- Austedo XR (Drug) $73.33
- RYBELSUS (Drug) $62.34
- Otezla (Drug) $61.90
- ELIQUIS (Drug) $43.92
- TRADJENTA (Drug) $39.99
- Livalo (Drug) $36.45
- Dexcom G6 Transmitter (Medical Supply) $33.60
- JANUVIA (Drug) $32.05
- HETLIOZ (Drug) $30.00
- VRAYLAR (Drug) $29.75
- Cologuard Collection Kit (Device) $27.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Louisville
Ruth Carrico, Rn, Msn, Phd, RN, MSN, PHD
Family — Payments: $403,371
Family $403,371
Ms. Smita Ranjan, Aprn, APRN
Family — Payments: $75,893
Family $75,893
Ashley Knable, Arnp, ARNP
Family — Payments: $75,423
Family $75,423
Danielle Revert, Aprn, APRN
Family — Payments: $64,469
Family $64,469
Mrs. Kassandra Green, Aprn, APRN
Family — Payments: $53,897
Family $53,897
Dr. Tracey Gaslin, Aprn, APRN
Family — Payments: $50,759
Family $50,759